RDIF, UNICEF sign  agreement for supply of 220 million doses of Sputnik V vaccine

Human Vaccine LLC, a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF) announces the signing of an agreement for the supply of 220 million doses of two-dose Sputnik V Russian COVID-19 vaccine with the United Nations International Children’s Emergency Fund (UNICEF). This amount is sufficient to vaccinate 110 million people.

A statement informed, “The supply agreement with UNICEF for Sputnik V vaccine will broaden access to help meet vaccine demand around the world. Procurement and delivery of the vaccine by UNICEF are subject to the vaccine receiving WHO Emergency Use Listing. The decision is expected soon on the Sputnik V application for WHO Emergency Use Listing that was submitted in October 2020.”

Concurrently, RDIF will be holding a separate discussion with Gavi, the Vaccine Alliance to see the Sputnik V vaccine considered for inclusion in the COVAX Facility’s Portfolio of COVID-19 vaccines.

Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said, “RDIF is proud to support UNICEF and its partners’ global efforts to ensure equal and wide access to coronavirus vaccines for all countries. Vaccination is the best way to defeat the pandemic, help people feel safe, restore economies and return to normal life. Sputnik V is already used in more than 40 countries and this number keeps increasing as we continue deliveries to our partners every day. RDIF looks forward to the successful completion of the WHO prequalification process and obtaining EUL to start delivering supplies of Sputnik V through UNICEF to save millions of lives.”